Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 29, 2007
- Accepted March 20, 2008
- Published online June 27, 2008.
Article Versions
- Earlier version (April 16, 2008 - 12:19).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2008 by the American Society of Nephrology
Author Information
- Rajnish Mehrotra* † ,
- Dulcie Kermah ‡ ,
- Matthew Budoff* † ,
- Isidro B. Salusky § ,
- Sang Shaou Mao*,
- Yan Lin Gao*,
- Junichiro Takasu*,
- Sharon Adler* † ,
- Keith Norris † ‡
- *Department of Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, and Departments of †Medicine and §Pediatrics, David Geffen School of Medicine at UCLA and ‡Department of Medicine, Charles Drew University, Los Angeles, California
- Correspondence:
Dr. Rajnish Mehrotra, 1124 W. Carson Street, Torrance, CA 90502. Phone: 310-222-3891; Fax: 310-782-1837; E-mail: rmehrotra{at}labiomed.org
Statistics from Altmetric.com
Article usage
Cited By...
In this issue
Hypovitaminosis D in Chronic Kidney Disease
Jump to section
More in this TOC Section
Cited By...
- Association between vitamin D deficiency and exercise capacity in patients with CKD, a cross-sectional analysis
- High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial
- Is Coronary Artery Calcification Associated with Vertebral Bone Density in Nondialyzed Chronic Kidney Disease Patients?
- Cardiorespiratory Fitness Is Independently Associated with 25-Hydroxyvitamin D in Chronic Kidney Disease
- Vitamin D Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Observational Studies and Randomized Controlled Trials
- Prevalence and Prognostic Significance of Renal Artery Calcification in Patients with Diabetes and Proteinuria
- A Randomized Trial of Cholecalciferol versus Doxercalciferol for Lowering Parathyroid Hormone in Chronic Kidney Disease
- Treatment of Secondary Hyperparathyroidism in CKD Patients with Cinacalcet and/or Vitamin D Derivatives